Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward E Cable

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Hepatology Communications|February 3, 2025
Peroxisome proliferator-activated receptor delta and liver diseasesTomoo Yamazaki, Edward E Cable, Bernd Schnabl
Current Research in Pharmacology and Drug Discovery|August 23, 2023
OCE-205 in rats and non-human primates: Pharmacokinetic and pharmacodynamic analysisStan Bukofzer, Geoff Harris, Edward E Cable
Journal of Experimental Pharmacology|July 20, 2023
OCE-205, a Selective V1a Partial Agonist, Reduces Portal Pressure in Rat Models of Portal HypertensionStan Bukofzer, Geoffrey Harris, Susan Song, et al.
The American Journal of Pathology|March 26, 2003
Expression of E-cadherin and other paracellular junction genes is decreased in iron-loaded hepatocytesJohn P Bilello, Edward E Cable, Harriet C Isom
DNA and Cell Biology|June 4, 2002
Effects of modulators of protein phosphorylation on heme metabolism in human hepatic cells: induction of delta-aminolevulinic synthase mRNA and protein by okadaic acidEdward E Cable, Benjamin R Kuhn, Harriet C Isom
Biological Trace Element Research|May 11, 2002
The lipophilic iron compound TMH-ferrocene [(3,5,5-trimethylhexanoyl)ferrocene] increases iron concentrations, neuronal L-ferritin, and heme oxygenase in brains of BALB/c miceElise A Malecki, Edward E Cable, Harriet C Isom, et al.
The Journal of Biological Chemistry|May 23, 2022
Selective PPARδ agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 via the fibroblast growth factor 21 signaling pathwayTetsuya Kouno, Xiao Liu, Huayi Zhao, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
Comparison of anti-hepatitis B virus activities of lamivudine and clevudine by a quantitative assayAyman M Abdelhamed, Colleen M Kelley, Thomas G Miller, et al.
PPAR Research|April 14, 2025
Single and Multiple Doses of Seladelpar Decrease Diurnal Markers of Bile Acid Synthesis in MiceEdward E Cable, Jeffrey W Stebbins, Jeff D Johnson, et al.
Hepatology (Baltimore, Md.)|December 17, 2008
Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonistEdward E Cable, Patricia D Finn, Jeffrey W Stebbins, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Hepatology Communications|February 3, 2025
Peroxisome proliferator-activated receptor delta and liver diseasesTomoo Yamazaki, Edward E Cable, Bernd Schnabl
Current Research in Pharmacology and Drug Discovery|August 23, 2023
OCE-205 in rats and non-human primates: Pharmacokinetic and pharmacodynamic analysisStan Bukofzer, Geoff Harris, Edward E Cable
Journal of Experimental Pharmacology|July 20, 2023
OCE-205, a Selective V1a Partial Agonist, Reduces Portal Pressure in Rat Models of Portal HypertensionStan Bukofzer, Geoffrey Harris, Susan Song, et al.
The American Journal of Pathology|March 26, 2003
Expression of E-cadherin and other paracellular junction genes is decreased in iron-loaded hepatocytesJohn P Bilello, Edward E Cable, Harriet C Isom
DNA and Cell Biology|June 4, 2002
Effects of modulators of protein phosphorylation on heme metabolism in human hepatic cells: induction of delta-aminolevulinic synthase mRNA and protein by okadaic acidEdward E Cable, Benjamin R Kuhn, Harriet C Isom
Biological Trace Element Research|May 11, 2002
The lipophilic iron compound TMH-ferrocene [(3,5,5-trimethylhexanoyl)ferrocene] increases iron concentrations, neuronal L-ferritin, and heme oxygenase in brains of BALB/c miceElise A Malecki, Edward E Cable, Harriet C Isom, et al.
The Journal of Biological Chemistry|May 23, 2022
Selective PPARδ agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 via the fibroblast growth factor 21 signaling pathwayTetsuya Kouno, Xiao Liu, Huayi Zhao, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2002
Comparison of anti-hepatitis B virus activities of lamivudine and clevudine by a quantitative assayAyman M Abdelhamed, Colleen M Kelley, Thomas G Miller, et al.
PPAR Research|April 14, 2025
Single and Multiple Doses of Seladelpar Decrease Diurnal Markers of Bile Acid Synthesis in MiceEdward E Cable, Jeffrey W Stebbins, Jeff D Johnson, et al.
Hepatology (Baltimore, Md.)|December 17, 2008
Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonistEdward E Cable, Patricia D Finn, Jeffrey W Stebbins, et al.
Pageof 2